Navigation Links
Qforma Appoints Two New Executives
Date:1/19/2009

SANTA FE, N.M., Jan. 19 /PRNewswire/ -- Qforma, an advanced analytics and predictive modeling company, today announced the appointments of Kristopher J. Wiggs as Vice President of Sales, New Business, and William Howard, Ph.D., as Director, Field Operations.

"As Qforma continues to grow, we are seeking the top commercial and scientific professionals in the business to better serve our clients," said Kelly D. Myers, CEO of Qforma. "Kris and Dr. Howard certainly meet those criteria, as they bring different sets of unique, relevant and impressive experience to our team."

Wiggs has served in various sales and sales management positions and brings to Qforma over 10 years of pharmaceutical industry experience. He joined Organon Pharmaceuticals USA (now Schering-Plough) as a sales representative in 1999 and was promoted to district manager in 2002. In the latter role, Wiggs was named District Manager of the Year and his teams won numerous awards, consistently finishing in the top 25 percent of the company in sales.

Dr. Howard, a physicist, joins Qforma following a diverse career in multiple technical fields. For the past eight years, Dr. Howard has developed and marketed computational lithography products for the semiconductor industry. A graduate with honors of the United States Military Academy at West Point, he served as a medical physicist and radiation safety officer at an Army medical center in Germany before earning his Ph.D. as a Hertz Foundation Fellow in Applied Nuclear and Medical Physics from the Massachusetts Institute of Technology. Dr. Howard has extensive experience working with customers in the U.S., Asia and Europe.

About Qforma

Qforma is an advanced analytics and predictive modeling company specializing in solutions for the pharmaceutical and biotech industries. Qforma leverages the talents of physicists, mathematicians and programmers, and has developed a unique approach to quantifying large data flows with the purpose of eliminating the inefficiencies of traditional sales and marketing techniques.

Qforma is headquartered in Santa Fe, NM, with offices in Boston, MA; Bucks County, PA; and Princeton, NJ. More information is located at http://www.Qforma.com.

    Media Contacts:
    Lisa Haley, Qforma
    (505) 603-7596
    lhaley@qforma.com

    Jeff Hoyak, MCS Public Relations
    (800) 477-9626
    jeffh@mcspr.com


'/>"/>
SOURCE Qforma
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
2. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
3. Jennerex Appoints Samantha Miller as Vice President of Corporate Development
4. Cumberland Pharmaceuticals Appoints Lee Product Director
5. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
6. NanoLogix Inc. Appoints Two New Directors and Provides Operations Update
7. French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees)
8. BioNanomatrix Appoints Michael Kochersperger as Vice President of Engineering
9. Agendia Appoints New Chief Financial Officer
10. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
11. Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... cells — optogenetics — is key to exciting advances in the study and ... patterned light projected via free-space optics stimulates small, transparent organisms and excites neurons ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc announced ... client demand KbioBox developed a sophisticated “3 click” gene dditing off target analysis ... KBioBox’s new website, https://www.kbiobox.com/ and powered by the company’s proprietary ...
(Date:12/8/2016)... 8, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... developing and commercializing products to treat rare diseases where ... it will be hosting an Investor Webcast Event Friday, ... origins of innate defense regulators (IDRs) as a new ... mucositis and the recently announced and published Phase 2 ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selector™ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
Breaking Biology Technology:
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):